Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Home
  • Home
Chapter
  • Print publication year: 2019
  • Online publication date: October 2019

Chapter 5 - Electro-clinical Syndromes and Epilepsies in the Neonatal Period, Infancy, and Childhood

Export citation

Summary

Apart from age of presentation, the electro-clinical syndromes are elaborated by a distinctive and recognizable set of features including the type of seizure(s) and the electrographic traits which aggregate together.1 Imaging findings can be considered. Neurodevelopmental and psychiatric comorbidities of varying degree are often associated. Causation may be included in the classification system. According to the 2017 position paper of the ILAE Commission for Classification and Terminology, the etiology of epilepsy may be structural, genetic, infectious, metabolic, or immune. Causation may also be unknown (formerly cryptogenic).2 Idiopathic and self-limited (formerly benign) epilepsies occur in children with a normal neurological examination and normal neuro-imaging, in whom there may be a familial predisposition. The term idiopathic (as opposed to genetic) is still preferred by some in respect of four well-recognized idiopathic generalized epilepsy syndromes (IGEs): childhood absence epilepsy (CAE), juvenile absence epilepsy (JAE), juvenile myoclonic epilepsy (JME), and generalized tonic–clonic seizures alone (formerly generalized tonic–clonic seizures on awakening). Although monogenic or more complex genetic or environmental susceptibility factors may be implicated in these epilepsies, the mechanisms are not always fully elucidated. The attribution to genetic causation may incorrectly suggest a high rate of inheritance. Benign focal epilepsies, such as benign or childhood epilepsy with centrotemporal spikes (CECTS) and the occipital lobe epilepsies of Panayiotopoulos and Gastaut are, again according to the position paper, termed self-limited as the term benign does not seem to fully address the developmental impact of these transient epilepsies.2 The epileptic encephalopathies, recognized as a distinct category, comprise a polymorphous group of epilepsy syndromes in which the epileptic activity itself contributes to cognitive and behavioral impairments above and beyond what might be expected from the underlying pathology alone.1 There is abundant epileptiform activity and inherently there is the idea that limiting or suppressing the activity will improve the neurodevelopmental outlook.

Related content

Powered by UNSILO
1.Berg, AT, Berkovic, SF, Brodie, MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005–2009. Epilepsia. 2010;51(4):676–685.
2.Scheffer, IE, Berkovic, S, Capovilla, G, et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):512–521.
3.Scheffer, IE, Harkin, LA, Dibbens, LM, Mulley, JC, Berkovic, SF. Neonatal epilepsy syndromes and generalized epilepsy with febrile seizures plus (GEFS+). Epilepsia. 2005;46(Suppl 10):41–47.
4.Hirsch, E, Velez, A, Sellal, F, et al. Electroclinical signs of benign neonatal familial convulsions. Ann Neurol. 1993;34(6):835–841.
5.Plouin, P, Neubauer, BA. Benign familial and non-familial neonatal seizures. In: Bureau, M, Genton, P, Dravet, C, et al., eds., Epileptic Syndromes in Infancy, Childhood and Adolescence. 5th edn. Montrouge, France: John Libbey Eurotext; 2012:77–88.
6.Yamamoto, H, Okumura, A, Fukuda, M. Epilepsies and epileptic syndromes starting in the neonatal period. Brain Dev. 2011;33(3):213–220.
7.Specchio, N, Vigevano, F. The spectrum of benign infantile seizures. Epilepsy Res. 2006;70(Suppl 1):S156–167.
8.Vigevano, F. Benign familial infantile seizures. Brain Dev. 2005;27(3):172–177.
9.Zara, F, Specchio, N, Striano, P, et al. Genetic testing in benign familial epilepsies of the first year of life: clinical and diagnostic significance. Epilepsia. 2013;54(3):425–436.
10.Berkovic, SF, Heron, SE, Giordano, L, et al. Benign familial neonatal-infantile seizures: characterization of a new sodium channelopathy. Ann Neurol. 2004;55(4):550–557.
11.Beal, JC, Cherian, K, Moshe, SL. Early-onset epileptic encephalopathies: Ohtahara syndrome and early myoclonic encephalopathy. Pediatr Neurol. 2012;47(5):317–323.
12.Ohtahara, S, Yamatogi, Y. Epileptic encephalopathies in early infancy with suppression-burst. J Clin Neurophysiol. 2003;20(6):398–407.
13.Djukic, A, Lado, FA, Shinnar, S, Moshe, SL. Are early myoclonic encephalopathy (EME) and the Ohtahara syndrome (EIEE) independent of each other? Epilepsy Res. 2006;70(Suppl 1):S68–76.
14.Ohtahara, S, Yamatogi, Y. Ohtahara syndrome: with special reference to its developmental aspects for differentiating from early myoclonic encephalopathy. Epilepsy Res. 2006;70(Suppl 1):S58–67.
15.Mizrahi, EM, Milh, M. Early severe neonatal and infantile epilepsies. In: Bureau, M, Genton, P, Dravet, C, et al., eds., Epileptic Syndromes in Infancy, Childhood and Adolescence. 5th edn. Montrouge, France: John Libbey Eurotext; 2012:89–98.
16.Pavone, P, Spalice, A, Polizzi, A, Parisi, P, Ruggieri, M. Ohtahara syndrome with emphasis on recent genetic discovery. Brain Dev. 2012;34(6):459–468.
17.Gursoy, S, Ercal, D. Diagnostic approach to genetic causes of early-onset epileptic encephalopathy. J Child Neurol. 2016;31(4):523–532.
18.Coppola, G. Malignant migrating partial seizures in infancy: an epilepsy syndrome of unknown etiology. Epilepsia. 2009;50(Suppl 5):49–51.
19.McTague, A, Appleton, R, Avula, S, et al. Migrating partial seizures of infancy: expansion of the electroclinical, radiological and pathological disease spectrum. Brain. 2013;136(Pt 5):1578–1591.
20.Marsh, E, Melamed, SE, Barron, T, Clancy, RR. Migrating partial seizures in infancy: expanding the phenotype of a rare seizure syndrome. Epilepsia. 2005;46(4):568–572.
21.Merdariu, D, Delanoe, C, Mahfoufi, N, Bellavoine, V, Auvin, S. Malignant migrating partial seizures of infancy controlled by stiripentol and clonazepam. Brain Dev. 2013;35(2):177–180.
22.Trevathan, E. Infantile spasms and Lennox-Gastaut syndrome. J Child Neurol. 2002;17(Suppl 2):2S9–2S22.
23.Pavone, P, Striano, P, Falsaperla, R, Pavone, L, Ruggieri, M. Infantile spasms syndrome, West syndrome and related phenotypes: what we know in 2013. Brain Dev. 2014;36(9):739–751.
24.Pellock, JM, Hrachovy, R, Shinnar, S, et al. Infantile spasms: a U.S. consensus report. Epilepsia. 2010;51(10):2175–2189.
25.Riikonen, R. Epidemiological data of West syndrome in Finland. Brain Dev. 2001;23(7):539–541.
26.Hrachovy, RA, Frost, JD Jr. Infantile epileptic encephalopathy with hypsarrhythmia (infantile spasms/West syndrome). J Clin Neurophysiol. 2003;20(6):408–425.
27.Fusco, L, Chiron, C, Trivisano, M, Vigevano, F, Chugani, HT. Infantile spasms. In: Bureau, M, Genton, P, Dravet, C, et al., eds., Epileptic Syndromes in Infancy, Childhood and Adolescence. 5th edn. Montrouge, France: John Libbey Eurotext; 2012:99–113.
28.Kramer, U, Sue, WC, Mikati, MA. Focal features in West syndrome indicating candidacy for surgery. Pediatr Neurol. 1997;16(3):213–217.
29.Osborne, JP, Lux, AL, Edwards, SW, et al. The underlying etiology of infantile spasms (West syndrome): information from the United Kingdom Infantile Spasms Study (UKISS) on contemporary causes and their classification. Epilepsia. 2010;51(10):2168–2174.
30.Wirrell, EC, Shellhaas, RA, Joshi, C, et al. How should children with West syndrome be efficiently and accurately investigated?: results from the National Infantile Spasms Consortium. Epilepsia. 2015;56(4):617–625.
31.Dulac, O. What is West syndrome? Brain Dev. 2001;23(7):447–452.
32.Fusco, L, Vigevano, F. Ictal clinical electroencephalographic findings of spasms in West syndrome. Epilepsia. 1993;34(4):671–678.
33.Drury, I, Beydoun, A, Garofalo, EA, Henry, TR. Asymmetric hypsarrhythmia: clinical electroencephalographic and radiological findings. Epilepsia. 1995;36(1):41–47.
34.Gaily, E, Liukkonen, E, Paetau, R, Rekola, R, Granstrom, ML. Infantile spasms: diagnosis and assessment of treatment response by video-EEG. Dev Med Child Neurol. 2001;43(10):658–667.
35.Oka, M, Kobayashi, K, Akiyama, T, Ogino, T, Oka, E. A study of spike-density on EEG in West syndrome. Brain Dev. 2004;26(2):105–112.
36.Mackay, MT, Weiss, SK, Adams-Webber, T, et al. Practice parameter: medical treatment of infantile spasms. Report of the American Academy of Neurology and the Child Neurology Society. Neurology. 2004;62(10):1668–1681.
37.Wilmshurst, JM, Gaillard, WD, Vinayan, KP, et al. Summary of recommendations for the management of infantile seizures: task force report for the ILAE Commission of Pediatrics. Epilepsia. 2015;56(8):1185–1197.
38.Hrachovy, RA, Frost, JD Jr., Glaze, DG. High-dose, long-duration versus low-dose, short-duration corticotropin therapy for infantile spasms. J Pediatr. 1994;124(5 Pt 1):803–806.
39.Wheless, JW, Clarke, DF, Carpenter, D. Treatment of pediatric epilepsy: expert opinion, 2005. J Child Neurol. 2005;20(Suppl 1):S1–56; quiz S59–60.
40.Vigevano, F, Cilio, MR. Vigabatrin versus ACTH as first-line treatment for infantile spasms: a randomized, prospective study. Epilepsia. 1997;38(12):1270–1274.
41.Brodie, SE. Screening for vigabatrin (Sabril®) retinal toxicity in children. Ophthalmic Genet. 2011;32(4):193–195.
42.Gaily, E, Jonsson, H, Lappi, M. Visual fields at school-age in children treated with vigabatrin in infancy. Epilepsia. 2009;50(2):206–216.
43.Pearl, PL, Vezina, LG, Saneto, RP, et al. Cerebral MRI abnormalities associated with vigabatrin therapy. Epilepsia. 2009;50(2):184–194.
44.Lux, AL, Edwards, SW, Hancock, E, et al. The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial. Lancet. 2004;364(9447):1773–1778.
45.Lux, AL, Edwards, SW, Hancock, E, et al. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial. Lancet Neurol. 2005;4(11):712–717.
46.Darke, K, Edwards, SW, Hancock, E, et al. Developmental and epilepsy outcomes at age 4 years in the UKISS trial comparing hormonal treatments to vigabatrin for infantile spasms: a multi-centre randomised trial. Arch Dis Child. 2010;95(5):382–386.
47.Chugani, HT. Pathophysiology of infantile spasms. Adv Exp Med Biol. 2002;497:111–121.
48.Chugani, HT, Shewmon, DA, Shields, WD, et al. Surgery for intractable infantile spasms: neuroimaging perspectives. Epilepsia. 1993;34(4):764–771.
49.Wong, M, Trevathan, E. Infantile spasms. Pediatr Neurol. 2001;24(2):89–98.
50.Kivity, S, Lerman, P, Ariel, R, et al. Long-term cognitive outcomes of a cohort of children with cryptogenic infantile spasms treated with high-dose adrenocorticotropic hormone. Epilepsia. 2004;45(3):255–262.
51.Kossoff, EH. Infantile spasms. Neurologist. 2010;16(2):69–75.
52.Marini, C, Scheffer, IE, Nabbout, R, et al. The genetics of Dravet syndrome. Epilepsia. 2011;52(Suppl 2):24–29.
53.Meisler, MH, Kearney, JA. Sodium channel mutations in epilepsy and other neurological disorders. J Clin Invest. 2005;115(8):2010–2017.
54.Wu, YW, Sullivan, J, McDaniel, SS, et al. Incidence of Dravet syndrome in a US population. Pediatrics. 2015;136(5):e1310–1315.
55.Dravet, C. The core Dravet syndrome phenotype. Epilepsia. 2011;52(Suppl 2):3–9.
56.Arzimanoglou, A. Dravet syndrome: from electroclinical characteristics to molecular biology. Epilepsia. 2009;50(Suppl 8):3–9.
57.Wirrell, EC, Laux, L, Donner, E, et al. Optimizing the diagnosis and management of Dravet syndrome: recommendations from a North American consensus panel. Pediatr Neurol. 2017;68:18–34 e13.
58.Oguni, H, Hayashi, K, Awaya, Y, Fukuyama, Y, Osawa, M. Severe myoclonic epilepsy in infants – a review based on the Tokyo Women’s Medical University series of 84 cases. Brain Dev. 2001;23(7):736–748.
59.Guerrini, R, Aicardi, J. Epileptic encephalopathies with myoclonic seizures in infants and children (severe myoclonic epilepsy and myoclonic-astatic epilepsy). J Clin Neurophysiol. 2003;20(6):449–461.
60.Gataullina, S, Dulac, O. From genotype to phenotype in Dravet disease. Seizure. 2017;44:58–64.
61.Dravet, C, Bureau, M, Oguni, H, Cokar, O, Guerrini, R. Dravet syndrome (severe myoclonic epilepsy in infancy). In: Bureau, M, Genton, P, Dravet, C, et al., eds., Epileptic Syndromes in Infancy, Childhood and Adolescence. 5th edn. Montrouge, France: John Libbey Eurotext; 2012:125–156.
62.Bureau, M, Dalla Bernardina, B. Electroencephalographic characteristics of Dravet syndrome. Epilepsia. 2011;52(Suppl 2):13–23.
63.Wolff, M, Casse-Perrot, C, Dravet, C. Severe myoclonic epilepsy of infants (Dravet syndrome): natural history and neuropsychological findings. Epilepsia. 2006;47(Suppl 2):45–48.
64.Genton, P, Velizarova, R, Dravet, C. Dravet syndrome: the long-term outcome. Epilepsia. 2011;52(Suppl 2):44–49.
65.Sakauchi, M, Oguni, H, Kato, I, et al. Mortality in Dravet syndrome: search for risk factors in Japanese patients. Epilepsia. 2011;52(Suppl 2):50–54.
66.Scheffer, IE, Berkovic, SF. Generalized epilepsy with febrile seizures plus: a genetic disorder with heterogeneous clinical phenotypes. Brain. 1997;120(Pt 3):479–490.
67.Camfield, P, Camfield, C. Febrile seizures and genetic epilepsy with febrile seizures plus (GEFS+). Epileptic Disord. 2015;17(2):124–133.
68.Scheffer, IE, Zhang, YH, Jansen, FE, Dibbens, L. Dravet syndrome or genetic (generalized) epilepsy with febrile seizures plus? Brain Dev. 2009;31(5):394–400.
69.De Jonghe, P. Molecular genetics of Dravet syndrome. Dev Med Child Neurol. 2011;53(Suppl 2):7–10.
70.Dravet, C, Bureau, M, Genton, P. Benign myoclonic epilepsy of infancy: electroclinical symptomatology and differential diagnosis from the other types of generalized epilepsy of infancy. Epilepsy Res Suppl. 1992;6:131–135.
71.Zuberi, SM, O’Regan, ME. Developmental outcome in benign myoclonic epilepsy in infancy and reflex myoclonic epilepsy in infancy: a literature review and six new cases. Epilepsy Res. 2006;70(Suppl 1):S110–115.
72.Hirano, Y, Oguni, H, Funatsuka, M, Imai, K, Osawa, M. Differentiation of myoclonic seizures in epileptic syndromes: a video-polygraphic study of 26 patients. Epilepsia. 2009;50(6):1525–1535.
73.Auvin, S, Pandit, F, De Bellecize, J, et al. Benign myoclonic epilepsy in infants: electroclinical features and long-term follow-up of 34 patients. Epilepsia. 2006;47(2):387–393.
74.Darra, F, Fiorini, E, Zoccante, L, et al. Benign myoclonic epilepsy in infancy (BMEI): a longitudinal electroclinical study of 22 cases. Epilepsia. 2006;47(Suppl 5):31–35.
75.Caraballo, RH, Flesler, S, Pasteris, MC, et al. Myoclonic epilepsy in infancy: an electroclinical study and long-term follow-up of 38 patients. Epilepsia. 2013;54(9):1605–1612.
76.Matricardi, S, Verrotti, A, Chiarelli, F, Cerminara, C, Curatolo, P. Current advances in childhood absence epilepsy. Pediatr Neurol. 2014;50(3):205–212.
77.Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia. 1989;30(4):389–399.
78.Panayiotopoulos, CP. Absence epilepsies. In: Engel, J, Pedley, TA, eds., Epilepsy: A Comprehensive Textbook. Philadelphia: Lippincott-Raven; 1998:2327–2346.
79.Sadleir, LG, Farrell, K, Smith, S, Connolly, MB, Scheffer, IE. Electroclinical features of absence seizures in childhood absence epilepsy. Neurology. 2006;67(3):413–418.
80.Panayiotopoulos, CP, Obeid, T, Waheed, G. Differentiation of typical absence seizures in epileptic syndromes: a video EEG study of 224 seizures in 20 patients. Brain. 1989;112(Pt 4):1039–1056.
81.Medina, MT, Bureau, M, Hirsch, E, Panayiotopoulos, CP. Childhood absence epilepsy. In: Bureau, M, Genton, P, Dravet, C, et al., eds., Epileptic Syndromes in Infancy, Childhood and Adolescence. 5th edn. Montrouge, France: John Libbey Eurotext; 2012:277–296.
82.Penry, JK, Porter, RJ, Dreifuss, RE. Simultaneous recording of absence seizures with video tape and electroencephalography. A study of 374 seizures in 48 patients. Brain. 1975;98(3):427–440.
83.Sadleir, LG, Scheffer, IE, Smith, S, Connolly, MB, Farrell, K. Automatisms in absence seizures in children with idiopathic generalized epilepsy. Arch Neurol. 2009;66(6):729–734.
84.Riviello, JJ Jr., Foley, CM. The epileptiform significance of intermittent rhythmic delta activity in childhood. J Child Neurol. 1992;7(2):156–160.
85.Guilhoto, LM, Manreza, ML, Yacubian, EM. Occipital intermittent rhythmic delta activity in absence epilepsy. Arq Neuropsiquiatr. 2006;64(2A):193–197.
86.Panayiotopoulos, CP, Engel, J Jr. Childhood absence epilepsy. http://www.medlink.com/article/childhood_absence_epilepsy. Accessed March 15, 2019.
87.Wirrell, EC, Camfield, CS, Camfield, PR, Gordon, KE, Dooley, JM. Long-term prognosis of typical childhood absence epilepsy: remission or progression to juvenile myoclonic epilepsy. Neurology. 1996;47(4):912–918.
88.Grosso, S, Galimberti, D, Vezzosi, P, et al. Childhood absence epilepsy: evolution and prognostic factors. Epilepsia. 2005;46(11):1796–1801.
89.Callenbach, PM, Bouma, PA, Geerts, AT, et al. Long-term outcome of childhood absence epilepsy: Dutch Study of Epilepsy in Childhood. Epilepsy Res. 2009;83(2–3):249–256.
90.Wirrell, E, Camfield, C, Camfield, P, Dooley, J. Prognostic significance of failure of the initial antiepileptic drug in children with absence epilepsy. Epilepsia. 2001;42(6):760–763.
91.Koutroumanidis, M, Bourvari, G, Tan, SV. Idiopathic generalized epilepsies: clinical and electroencephalogram diagnosis and treatment. Expert Rev Neurother. 2005;5(6):753–767.
92.Trinka, E, Baumgartner, S, Unterberger, I, et al. Long-term prognosis for childhood and juvenile absence epilepsy. J Neurol. 2004;251(10):1235–1241.
93.Shinnar, S, Cnaan, A, Hu, F, et al. Long-term outcomes of generalized tonic-clonic seizures in a childhood absence epilepsy trial. Neurology. 2015;85(13):1108–1114.
94.Glauser, TA, Cnaan, A, Shinnar, S, et al. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy. N Engl J Med. 2010;362(9):790–799.
95.Masur, D, Shinnar, S, Cnaan, A, et al. Pretreatment cognitive deficits and treatment effects on attention in childhood absence epilepsy. Neurology. 2013;81(18):1572–1580.
96.Wirrell, EC, Camfield, CS, Camfield, PR, et al. Long-term psychosocial outcome in typical absence epilepsy: sometimes a wolf in sheeps’ clothing. Arch Pediatr Adolesc Med. 1997;151(2):152–158.
97.Bureau, M, Tassinari, CA. Myoclonic absences and absences with myoclonias. In: Bureau, M, Genton, P, Dravet, C, et al., eds., Epileptic Syndromes in Infancy and Childhood and Adolescence. 5th edn. Montrouge, France: John Libbey Eurotext; 2012:297–304.
98.Larsson, K, Eeg-Olofsson, O. A population based study of epilepsy in children from a Swedish county. Eur J Paediatr Neurol. 2006;10(3):107–113.
99.Panayiotopoulos, CP, Michael, M, Sanders, S, Valeta, T, Koutroumanidis, M. Benign childhood focal epilepsies: assessment of established and newly recognized syndromes. Brain. 2008;131(Pt 9):2264–2286.
100.Ma, CK, Chan, KY. Benign childhood epilepsy with centrotemporal spikes: a study of 50 Chinese children. Brain Dev. 2003;25(6):390–395.
101.Panayiotopoulos, CP, Bureau, M, Caraballo, RH, Bernardina, DB, Valeta, T. Idiopathic focal epilepsies in childhood. In: Bureau, M, Genton, P, Dravet, C, et al., eds., Epileptic Syndromes in Infancy, Childhood and Adolescence. 5th edn. Montrouge, France: John Libbey Eurotext; 2012:218–254.
102.Parakh, M, Katewa, V. A review of the not so benign- benign childhood epilepsy with centrotemporal spikes. J Neurol Neurophysiol. 2015;6:314.
103.Guerrini, R, Pellacani, S. Benign childhood focal epilepsies. Epilepsia. 2012;53(Suppl 4):9–18.
104.Panayiotopoulos, CP. Benign Childhood Partial Seizures and Related Epileptic Syndromes. London: John Libbey; 1999.
105.Arzimanoglou, A, Guerrini, R, Aicardi, J, eds. Aicardi’s Epilepsy in Children. 3rd edn. Philadelphia: Lippincott Williams & Wilkins; 2004.
106.Lerman, P. Benign childhood epilepsy with centro temporal spikes (BECTS). In: Engel, J, Pedley, TA, Aicardi, J, eds., Epilepsy: A Comprehensive Textbook. Philadelphia: Lippincott-Raven; 1998:2307–2314.
107.Legarda, S, Jayakar, P, Duchowny, M, Alvarez, L, Resnick, T. Benign rolandic epilepsy: high central and low central subgroups. Epilepsia. 1994;35(6):1125–1129.
108.Luders, H, Lesser, RP, Dinner, DS, Morris, HH III. Benign focal epilepsies of childhood. In: Luders, H, Lesser, RP, eds., Epilepsy: Electroclinical Syndromes. London: Springer-Verlag; 1987:303–346.
109.Jung, KY, Kim, JM, Kim, DW. Patterns of interictal spike propagation across the central sulcus in benign rolandic epilepsy. Clin Electroencephalogr. 2003;34(3):153–157.
110.Boor, R, Jacobs, J, Hinzmann, A, et al. Combined spike-related functional MRI and multiple source analysis in the non-invasive spike localization of benign rolandic epilepsy. Clin Neurophysiol. 2007;118(4):901–909.
111.Huiskamp, G, van Der Meij, W, van Huffelen, A, van Nieuwenhuizen, O. High resolution spatio-temporal EEG-MEG analysis of rolandic spikes. J Clin Neurophysiol. 2004;21(2):84–95.
112.Holmes, GL. Benign focal epilepsies of childhood. Epilepsia. 1993;34(Suppl 3):S49–61.
113.Cavazzuti, GB, Cappella, L, Nalin, A. Longitudinal study of epileptiform EEG patterns in normal children. Epilepsia. 1980;21(1):43–55.
114.Loiseau, P, Beaussart, M. The seizures of benign childhood epilepsy with Rolandic paroxysmal discharges. Epilepsia. 1973;14(4):381–389.
115.Bouma, PA, Bovenkerk, AC, Westendorp, RG, Brouwer, OF. The course of benign partial epilepsy of childhood with centrotemporal spikes: a meta-analysis. Neurology. 1997;48(2):430–437.
116.Loiseau, P, Duche, B, Cordova, S, Dartigues, JF, Cohadon, S. Prognosis of benign childhood epilepsy with centrotemporal spikes: a follow-up study of 168 patients. Epilepsia. 1988;29(3):229–235.
117.Coppola, G, Franzoni, E, Verrotti, A, et al. Levetiracetam or oxcarbazepine as monotherapy in newly diagnosed benign epilepsy of childhood with centrotemporal spikes (BECTS): an open-label, parallel group trial. Brain Dev. 2007;29(5):281–284.
118.Lerman, P. Seizures induced or aggravated by anticonvulsants. Epilepsia. 1986;27(6):706–710.
119.Parmeggiani, L, Seri, S, Bonanni, P, Guerrini, R. Electrophysiological characterization of spontaneous and carbamazepine-induced epileptic negative myoclonus in benign childhood epilepsy with centro-temporal spikes. Clin Neurophysiol. 2004;115(1):50–58.
120.Clarke, T, Strug, LJ, Murphy, PL, et al. High risk of reading disability and speech sound disorder in rolandic epilepsy families: case-control study. Epilepsia. 2007;48(12):2258–2265.
121.Bulgheroni, S, Franceschetti, S, Vago, C, et al. Verbal dichotic listening performance and its relationship with EEG features in benign childhood epilepsy with centrotemporal spikes. Epilepsy Res. 2008;79(1):31–38.
122.Shields, WD, Snead, OC, 3rd. Benign epilepsy with centrotemporal spikes. Epilepsia. 2009;50(Suppl 8):10–15.
123.Ferrie, C, Caraballo, R, Covanis, A, et al. Panayiotopoulos syndrome: a consensus view. Dev Med Child Neurol. 2006;48(3):236–240.
124.Martinovic, Z. The new ILAE report on classification and evidence-based commentary on Panayiotopoulos syndrome and autonomic status epilepticus. Epilepsia. 2007;48(6):1215–1216.
125.Panayiotopoulos, CP. Vomiting as an ictal manifestation of epileptic seizures and syndromes. J Neurol Neurosurg Psychiatry. 1988;51(11):1448–1451.
126.Panayiotopoulos, CP. Panayiotopoulos Syndrome: A Common and Benign Childhood Epileptic Syndrome. Eastleigh, England: John Libbey; 2002.
127.Covanis, A. Panayiotopoulos syndrome: a benign childhood autonomic epilepsy frequently imitating encephalitis, syncope, migraine, sleep disorder, or gastroenteritis. Pediatrics. 2006;118(4):e1237–1243.
128.Oguni, H, Hayashi, K, Imai, K, et al. Study on the early-onset variant of benign childhood epilepsy with occipital paroxysms otherwise described as early-onset benign occipital seizure susceptibility syndrome. Epilepsia. 1999;40(7):1020–1030.
129.Dura-Trave, T, Yoldi-Petri, ME, Gallinas-Victoriano, F. Panayiotopoulos syndrome: epidemiological and clinical characteristics and outcome. Eur J Neurol. 2008;15(4):336–341.
130.Leal, AJ, Nunes, S, Dias, AI, et al. Analysis of the generators of epileptic activity in early-onset childhood benign occipital lobe epilepsy. Clin Neurophysiol. 2007;118(6):1341–1347.
131.Kikumoto, K, Yoshinaga, H, Oka, M, et al. EEG and seizure exacerbation induced by carbamazepine in Panayiotopoulos syndrome. Epileptic Disord. 2006;8(1):53–56.
132.Caraballo, RH, Cersosimo, RO, Fejerman, N. Childhood occipital epilepsy of Gastaut: a study of 33 patients. Epilepsia. 2008;49(2):288–297.
133.Sanchez Fernandez, I, Loddenkemper, T. Pediatric focal epilepsy syndromes. J Clin Neurophysiol. 2012;29(5):425–440.
134.Ferini-Strambi, L, Sansoni, V, Combi, R. Nocturnal frontal lobe epilepsy and the acetylcholine receptor. Neurologist. 2012;18(6):343–349.
135.Tinuper, P, Bisulli, F, Cross, JH, et al. Definition and diagnostic criteria of sleep-related hypermotor epilepsy. Neurology. 2016;86(19):1834–1842.
136.Picard, F, Scheffer, IE. Genetically determined focal epilepsies. In: Bureau, M, Genton, P, Dravet, C, et al., eds., Epileptic Syndromes in Infancy, Childhood and Adolescence. 5th edn. Montrouge, France: John Libbey Eurotext; 2012:349–361.
137.Tinuper, P, Bisulli, F. From nocturnal frontal lobe epilepsy to sleep-related hypermotor epilepsy: a 35-year diagnostic challenge. Seizure. 2017;44:87–92.
138.Combi, R, Dalpra, L, Tenchini, ML, Ferini-Strambi, L. Autosomal dominant nocturnal frontal lobe epilepsy – a critical overview. J Neurol. 2004;251(8):923–934.
139.Arzimanoglou, A, French, J, Blume, WT, et al. Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology. Lancet Neurol. 2009;8(1):82–93.
140.Trevathan, E, Murphy, CC, Yeargin-Allsopp, M. Prevalence and descriptive epidemiology of Lennox-Gastaut syndrome among Atlanta children. Epilepsia. 1997;38(12):1283–1288.
141.Hancock, EC, Cross, JH. Treatment of Lennox-Gastaut syndrome. Cochrane Database Syst Rev. 2013(2):CD003277.
142.Markand, ON. Lennox-Gastaut syndrome (childhood epileptic encephalopathy). J Clin Neurophysiol. 2003;20(6):426–441.
143.Camfield, P, Camfield, C. Long-term prognosis for symptomatic (secondarily) generalized epilepsies: a population-based study. Epilepsia. 2007;48(6):1128–1132.
144.Camfield, PR. Definition and natural history of Lennox-Gastaut syndrome. Epilepsia. 2011;52(Suppl 5):3–9.
145.Dulac, O, N’Guyen, T. The Lennox-Gastaut syndrome. Epilepsia. 1993;34(Suppl 7):S7–17.
146.Chatrian, GE, Lettich, E, Wilkus, RJ, Vallarta, J. Polygraphic and clinical observations on tonic-autonomic seizures. Electroencephalogr Clin Neurophysiol Suppl. 1982(35):101–124.
147.Crumrine, PK. Lennox-Gastaut syndrome. J Child Neurol. 2002;17(Suppl 1):S70–75.
148.Gastraut, H, Roger, J, Soulayrol, R, et al. Childhood epileptic encephalopathy with diffuse slow spike-waves (otherwise known as “petit mal variant”) or Lennox syndrome. Epilepsia. 1966;7(2):139–179.
149.Crespel, A, Gelisse, P, Nikanorova, M, Ferlazzo, E, Genton, P. Lennox-Gastaut syndrome. In: Bureau, M, Genton, P, Dravet, C, et al., eds., Epileptic Syndromes in Infancy, Childhood and Adolescence. 5th edn. Montrouge, France: John Libbey Eurotext; 2012:189–216.
150.Yaqub, BA. Electroclinical seizures in Lennox-Gastaut syndrome. Epilepsia. 1993;34(1):120–127.
151.Camfield, P, Camfield, C. Epileptic syndromes in childhood: clinical features, outcomes, and treatment. Epilepsia. 2002;43(Suppl 3):27–32.
152.Ikeno, T, Shigematsu, H, Miyakoshi, M, et al. An analytic study of epileptic falls. Epilepsia. 1985;26(6):612–621.
153.Egli, M, Mothersill, I, O’Kane, M, O’Kane, F. The axial spasm – the predominant type of drop seizure in patients with secondary generalized epilepsy. Epilepsia. 1985;26(5):401–415.
154.Markand, ON. Slow spike-wave activity in EEG and associated clinical features: often called ‘Lennox’ or “Lennox-Gastaut’ syndrome. Neurology. 1977;27(8):746–757.
155.Zupanc, ML. Clinical evaluation and diagnosis of severe epilepsy syndromes of early childhood. J Child Neurol. 2009;24(8 Suppl):6S–14S.
156.Blume, WT. Pathogenesis of Lennox-Gastaut syndrome: considerations and hypotheses. Epileptic Disord. 2001;3(4):183–196.
157.Genton, P, Dravet, C. Lennox-Gastaut syndrome. In: Engel, J, Pedley, TA, eds. Epilepsy: A Comprehensive Textbook. Philadelphia: Lippincott-Raven; 1998:2355–2366.
158.Ohtahara, S, Ohtsuka, Y, Kobayashi, K. Lennox-Gastaut syndrome: a new vista. Psychiatry Clin Neurosci. 1995;49(3):S179–183.
159.VanStraten, AF, Ng, YT. Update on the management of Lennox-Gastaut syndrome. Pediatr Neurol. 2012;47(3):153–161.
160.Bourgeois, BF, Douglass, LM, Sankar, R. Lennox-Gastaut syndrome: a consensus approach to differential diagnosis. Epilepsia. 2014;55(Suppl 4):4–9.
161.Ostendorf, AP, Ng, YT. Treatment-resistant Lennox-Gastaut syndrome: therapeutic trends, challenges and future directions. Neuropsychiatr Dis Treat. 2017;13:1131–1140.
162.Lancman, G, Virk, M, Shao, H, et al. Vagus nerve stimulation vs. corpus callosotomy in the treatment of Lennox-Gastaut syndrome: a meta-analysis. Seizure. 2013;22(1):3–8.
163.Kelley, SA, Kossoff, EH. Doose syndrome (myoclonic-astatic epilepsy): 40 years of progress. Dev Med Child Neurol. 2010;52(11):988–993.
164.Oguni, H, Fukuyama, Y, Tanaka, T, et al. Myoclonic-astatic epilepsy of early childhood – clinical and EEG analysis of myoclonic-astatic seizures, and discussions on the nosology of the syndrome. Brain Dev. 2001;23(7):757–764.
165.Neubauer, BA, Hahn, A, Doose, H, Tuxhorn, I. Myoclonic-astatic epilepsy of early childhood – definition, course, nosography, and genetics. Adv Neurol. 2005;95:147–155.
166.Guerrini, R, Mari, F, Dravet, C. Idiopathic myoclonic epilepsies in infancy and early childhood. In: Bureau, M, Genton, P, Dravet, C, et al., eds., Epileptic Syndromes in Infancy, Childhood and Adolescence. 5th edn. Montrouge, France: John Libbey Eurotext; 2012:157–173.
167.Kramer, U. Atypical presentations of benign childhood epilepsy with centrotemporal spikes: a review. J Child Neurol. 2008;23(7):785–790.
168.Panayiotopoulos, CP. Syndromes of idiopathic generalized epilepsies not recognized by the International League Against Epilepsy. Epilepsia. 2005;46(Suppl 9):57–66.
169.Striano, S, Capovilla, G, Sofia, V, et al. Eyelid myoclonia with absences (Jeavons syndrome): a well-defined idiopathic generalized epilepsy syndrome or a spectrum of photosensitive conditions? Epilepsia. 2009;50(Suppl 5):15–19.
170.Caraballo, RH, Fontana, E, Darra, F, et al. A study of 63 cases with eyelid myoclonia with or without absences: type of seizure or an epileptic syndrome? Seizure. 2009;18(6):440–445.
171.Nar Senol, P, Tezer, FI, Saygi, S. Eyelid myoclonia seizures in adults: an alternate look at the syndrome paradox. Epilepsy Behav. 2015;45:265–270.
172.Destina Yalcin, A, Forta, H, Kilic, E. Overlap cases of eyelid myoclonia with absences and juvenile myoclonic epilepsy. Seizure. 2006;15(6):359–365.
173.da Conceicao, PO, Guaranha, MS, Uchida, CG, et al. Blinking and eyelid myoclonia: characteristics and correlations of eyelid movements. Seizure. 2015;24:12–16.
174.Nickels, K, Wirrell, E. Electrical status epilepticus in sleep. Semin Pediatr Neurol. 2008;15(2):50–60.
175.Smith, MC, Hoeppner, TJ. Epileptic encephalopathy of late childhood: Landau-Kleffner syndrome and the syndrome of continuous spikes and waves during slow-wave sleep. J Clin Neurophysiol. 2003;20(6):462–472.
176.Tuft, M, Arva, M, Bjornvold, M, Wilson, JA, Nakken, KO. Landau-Kleffner syndrome. Tidsskr Nor Laegeforen. 2015;135(22):2061–2064.
177.Tassinari, CA, Cantalupo, G, Dalla Bernadina, B, et al. Encephalopathy related to status epilepticus during slow wave sleep (ESES) including Landau-Kleffner syndrome. In: Bureau, M, Genton, P, Dravet, C, et al., eds., Epileptic Syndromes in Infancy, Childhood and Adolescence. 5th edn. Montrouge, France: John Libbey Eurotext; 2012:255–275.
178.Stefanatos, G. Changing perspectives on Landau-Kleffner syndrome. Clin Neuropsychol. 2011;25(6):963–988.
179.Smith, MC. Landau-Kleffner syndrome and continuous spike and waves during slow sleep. In: Engel, J Jr., Pedley, TA, eds., Epilepsy: A Comprehensive Textbook. Philadelphia: Lippincott-Raven; 1998:2367–2377.
180.Shimada, T, Takemiya, T, Sugiura, H, Yamagata, K. Role of inflammatory mediators in the pathogenesis of epilepsy. Mediators Inflamm. 2014;2014:901902.
181.Loddenkemper, T, Fernandez, IS, Peters, JM. Continuous spike and waves during sleep and electrical status epilepticus in sleep. J Clin Neurophysiol. 2011;28(2):154–164.
182.Hughes, JR. A review of the relationships between Landau-Kleffner syndrome, electrical status epilepticus during sleep, and continuous spike-waves during sleep. Epilepsy Behav. 2011;20(2):247–253.
183.Sanchez Fernandez, I, Loddenkemper, T, Peters, JM, Kothare, SV. Electrical status epilepticus in sleep: clinical presentation and pathophysiology. Pediatr Neurol. 2012;47(6):390–410.
184.Tassinari, CA, Rubboli, G, Volpi, L, et al. Encephalopathy with electrical status epilepticus during slow sleep or ESES syndrome including the acquired aphasia. Clin Neurophysiol. 2000;111(Suppl 2):S94–S102.
185.Guerrini, R, Genton, P, Bureau, M, et al. Multilobar polymicrogyria, intractable drop attack seizures, and sleep-related electrical status epilepticus. Neurology. 1998;51(2):504–512.
186.Smith, MC, Spitz, MC. Treatment strategies in Landau-Kleffner syndrome and paraictal psychiatric and cognitive disturbances. Epilepsy Behav. 2002;3(5S):24–29.
187.Buzatu, M, Bulteau, C, Altuzarra, C, Dulac, O, Van Bogaert, P. Corticosteroids as treatment of epileptic syndromes with continuous spike-waves during slow-wave sleep. Epilepsia. 2009;50(Suppl 7):68–72.
188.De Negri, M, Baglietto, MG, Battaglia, FM, et al. Treatment of electrical status epilepticus by short diazepam (DZP) cycles after DZP rectal bolus test. Brain Dev. 1995;17(5):330–333.
189.Morrell, F, Whisler, WW, Smith, MC, et al. Landau-Kleffner syndrome. Treatment with subpial intracortical transection. Brain. 1995;118(Pt 6):1529–1546.
190.Wolf, P. Basic principles of the ILAE syndrome classification. Epilepsy Res. 2006;70(Suppl 1):S20–26.